Keenan Greg bought AUPH
February 27, 2026 · Form 4 insider transaction
Keenan Greg bought 40,586 shares of Aurinia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,586
Price
$0.00
Total value
N/A
InsiderKeenan Greg
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after162,518
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement.